GB9202311D0 - Benzoyl carbinol and its esters,useful as inhibitors of angiogenesis - Google Patents

Benzoyl carbinol and its esters,useful as inhibitors of angiogenesis

Info

Publication number
GB9202311D0
GB9202311D0 GB929202311A GB9202311A GB9202311D0 GB 9202311 D0 GB9202311 D0 GB 9202311D0 GB 929202311 A GB929202311 A GB 929202311A GB 9202311 A GB9202311 A GB 9202311A GB 9202311 D0 GB9202311 D0 GB 9202311D0
Authority
GB
United Kingdom
Prior art keywords
angiogenesis
inhibitors
esters
useful
carbinol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB929202311A
Other versions
GB2252498A (en
GB2252498B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Publication of GB9202311D0 publication Critical patent/GB9202311D0/en
Publication of GB2252498A publication Critical patent/GB2252498A/en
Application granted granted Critical
Publication of GB2252498B publication Critical patent/GB2252498B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB9202311A 1991-02-05 1992-02-04 Benzoyl carbinol and its esters,useful as inhibitors of angiogenesis Expired - Fee Related GB2252498B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910276A IT1247827B (en) 1991-02-05 1991-02-05 BENZOIL CARBINOL AND ITS ESTERS, USEFUL AS ANGIOGENIC INHIBITORS

Publications (3)

Publication Number Publication Date
GB9202311D0 true GB9202311D0 (en) 1992-03-18
GB2252498A GB2252498A (en) 1992-08-12
GB2252498B GB2252498B (en) 1994-09-14

Family

ID=11358413

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9202311A Expired - Fee Related GB2252498B (en) 1991-02-05 1992-02-04 Benzoyl carbinol and its esters,useful as inhibitors of angiogenesis

Country Status (4)

Country Link
JP (1) JPH04338328A (en)
DE (1) DE4203116A1 (en)
GB (1) GB2252498B (en)
IT (1) IT1247827B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115974758A (en) * 2022-12-14 2023-04-18 生物岛实验室 Carboxymethyl ketone compound and preparation method thereof

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
PL328519A1 (en) * 1996-02-19 1999-02-01 Japan Tobacco Inc Antidiabetic therapeutic agent
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
CA2558014A1 (en) 2004-03-12 2005-09-29 Entremed, Inc. Antiangiogenic agents
US8399440B2 (en) 2006-03-20 2013-03-19 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115974758A (en) * 2022-12-14 2023-04-18 生物岛实验室 Carboxymethyl ketone compound and preparation method thereof

Also Published As

Publication number Publication date
IT1247827B (en) 1995-01-02
ITMI910276A0 (en) 1991-02-05
GB2252498A (en) 1992-08-12
GB2252498B (en) 1994-09-14
ITMI910276A1 (en) 1992-08-05
JPH04338328A (en) 1992-11-25
DE4203116A1 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
EP0572675A4 (en) Polyhydroxy carboxylic acid and production thereof
EP0520336A3 (en) Aldehyde derivatives and their use as calpain inhibitors
EP0500224A3 (en) Exonuclease mediated strand displacement amplification
HK1004335A1 (en) Novel steroid esters
HU9400952D0 (en) Heteroaryl-amines as acetyl-cholinesterase inhibitors
ZA923279B (en) Substituted carboxylic acid derivatives
GB2252498B (en) Benzoyl carbinol and its esters,useful as inhibitors of angiogenesis
EP0542630A3 (en) Use of derivatives of amphotericin b as protease inhibitors
HU9202817D0 (en) Bicyclical carboxylic acid derivatives
GB9219741D0 (en) Pyranones
GB9106569D0 (en) Starch esters
CS270191A3 (en) Acrylate esters of 1,1,1-trishydroxyphenyl ethane
EP0531821A3 (en) 1-alkoxyhexatriene-2-carboxylic acid esters
AU1576192A (en) Conserving cremains
AU2450592A (en) Top submergable lance
EP0643054A3 (en) Methods of producing carboxylic acid ester derivatives and intermediates for use in the methods.
EP0484949A3 (en) Ester inhibitors
GB2256105B (en) Limiting amplifier
AU4065993A (en) Saturated, monocarboxylic acids, the preparation thereof, and derivatives therefrom
AU1890092A (en) Novel ester derivatives of ryanodine and dehydroryanodine
IL103938A0 (en) Novel phenylsulfonylacrylate ester derivatives
HK25496A (en) Radiation-sensitive ester and process for its production
AU2915392A (en) Inhibition of angiogenesis with pyridinyloxazole-2-ones
AU3174393A (en) Knock down furniture
GB8908987D0 (en) Angiogenesis inhibitor

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19970204